Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01447188Case File
efta-efta01447188DOJ Data Set 10CorrespondenceEFTA Document EFTA01447188
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01447188
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
As of 4/16/14 11;23 pm
Description
Trade Date
Quantity
Current Price
Unit Cost
Market Value
Current Total Cost
Unrealized G/L
SANGAMO BIOSCIENCES
5/28/2013
50,000.00
$
14.12
$
8.44
$
706,000.00
422,214.00 $
283,786.00
BIOGEN
2/14/2012
2,095.00
$
290.72
$
119.55
$
609,058.40
250,454.95 $
358,603.45
FOUNDATION MEDICINE
1/13/2014
25,000.00
$
27.27
$
27.51
$
681,625.00
687,663.50 $
(6,038.50)
GILEAD SCIENCES INC
Multiple
8,100.00
$
69.31
$
79.41
$
561,402.90
643,204.00
$
(81,801.10)
Total Biotech
$
2,558,086.30
$
2,003,536.45
$
554,549.85
PX_LAST
ARIAD PHARMACEUTICALS
Multiple
16,535.00
$
6.83
5
17.60
$
112,934.05
290,997.40 S
(178,063.35)
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0101743
SDNY_GM_00247927
EFTA01447188
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.